运动方式对正常压力绝经后妇女运动后低血压的影响:对血管运动症状影响的随机对照试验
Morgane Le Bourvellec1, Nathalie Delpech1, Philippe Sosner1,2
1Laboratory MOVE (UR 20296), Faculté des Sciences du Sport, Université de Poitiers, Poitiers, France.
European journal of sport science
|November 22, 2025
概括
高强度间歇运动 (HIIE) 和同度阻力运动 (IRE) 都会在绝经后的女性中诱导运动后低血压 (PEH). IRE改善了夜间血压,增加了,而HIIE在运动后不久降低了血压.
科学领域:
- 心血管健康 心血管健康
- 运动生理学 运动生理学
- 绝经研究 绝经研究
背景情况:
- 更年期与血压升高 (BP) 和血管运动症状 (VMS) 相关,增加心血管风险.
- 运动后低血压 (PEH) 是一种运动后血压下降的现象,根据运动类型和个人因素,反应会有所不同.
研究的目的:
- 调查高强度间歇运动 (HIIE) 和同度阻力运动 (IRE) 对正常压力绝经后妇女的PEH的影响.
- 探索VMS如何影响这个人群中的PEH反应.
主要方法:
- 一个交叉随机对照试验,涉及29名绝经后妇女 (年龄55±3岁),有或没有VMS.
- 干预包括HIIE,IRE和控制 (CONT) 会议,PEH在会议后30分钟和24小时进行评估.
主要成果:
- 与运动前和运动后相比,HIIE在运动后30分钟诱导了显著的缩性PEH.
- 与CONT和HIIE相比,IRE导致夜间缩和腹缩血压下降,增加了夜间血压下降的比例.
- 在患有VMS的女性中,IRE导致夜间SBP比HIIE更低.
结论:
- 无论是HIIE还是IRE都有效地诱导了绝经后妇女的PEH.
- HIIE提供短期的BP降低,而IRE提供持续的夜间BP好处并改善浸泡状态.
- 在患有VMS的绝经后妇女中,运动对夜间BP反应是依赖于模式的.
相关概念视频
01:29Hypertension II: Pathophysiology
763
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
763
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
595
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
595
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
451
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
451
01:18Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
01:17Hormonal Regulation of Blood Pressure
5.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895